CLINICAL_TRIALS
trial_result
· 2014-06-24
Clinical Trial Update: Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) [Phase 4]
Summary
Phase 4 trial update of azacitidine in adult Taiwanese patients with higher-risk myelodysplastic syndromes has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Myelodysplastic Syndromes | Phase 4 | Status: COMPLETED | Results posted: 2014-06-24